Technology | 2018.11.01
Inscripta Hires Chief Commercial Officer Jason T. Gammack to Bring Gene-Editing Tools to Market
BOULDER, Colo., Nov. 1, 2018 /PRNewswire/ -- Inscripta™, a leading gene-editing technology company, today announced the addition of Jason T. Gammack as the company\'s first chief commercial officer. Gammack, a 25-year veteran of life sciences commercial operations, will leverage his...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]tools-to-market-300742413.html
